Enhancing safe and effective treatment of carbapenem-resistant Klebsiella pneumoniae with polymyxin B-loaded dendritic nanoparticles

被引：0
|
作者：
Zhong, Wen [1 ]
Fu, Yuyin [4 ]
Liao, Xukun [1 ]
Xu, Na [3 ]
Shen, Lingyi [3 ]
Wu, Jinglin [3 ]
Zheng, Dan [1 ]
Zhou, Yadi [1 ]
Tan, Lin [1 ]
Xia, Binyi [1 ]
Fan, Xinghua [1 ]
Zhou, Meng [5 ]
Yao, Yongchao [2 ]
Yang, Chengli [1 ]
机构：
[1] Department of Pharmacy, The Affiliated Hospital of Guizhou Medical University, Guizhou, Guiyang,550004, China
[2] Precision Medicine Translational Research Center, West China Hospital, Sichuan University, Sichuan, Chengdu,610041, China
[3] School of Basic Medicine, Guizhou Medical University, Guizhou, Guiyang,550025, China
[4] Department of Clinical Laboratory, Guizhou Provincial People's Hospital, Guizhou, Guiyang,550004, China
[5] State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang,550004, China
来源：
Chemical Engineering Journal | 1600年 / 498卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Carbapenem-Resistant Klebsiella pneumoniae: Virulence Factors, Molecular Epidemiology and Latest Updates in Treatment Options
    Karampatakis, Theodoros
    Tsergouli, Katerina
    Behzadi, Payam
    ANTIBIOTICS-BASEL, 2023, 12 (02):
  • [42] Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections in Patients With Liver Cirrhosis
    Feldman, Shani
    Russo, Alessandro
    Ceccarelli, Giancarlo
    Borrazzo, Cristian
    Madge, Chiara
    Venditti, Mario
    Merli, Manuela
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (05) : 1293 - 1300
  • [43] Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant Klebsiella pneumoniae in vitro
    Yu, Lan
    Zhang, Jisheng
    Fu, Yanjun
    Zhao, Yongxin
    Wang, Yong
    Zhao, Jing
    Guo, Yuhang
    Li, Chunjiang
    Zhang, Xiaoli
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [44] Antibiofilm Effect of Biogenic Silver Nanoparticles Combined with Oregano Derivatives against Carbapenem-Resistant Klebsiella pneumoniae
    Scandorieiro, Sara
    Teixeira, Franciele Maira M. B.
    Nogueira, Mara C. L.
    Panagio, Luciano A. A.
    de Oliveira, Admilton G. G.
    Duran, Nelson
    Nakazato, Gerson
    Kobayashi, Renata K. T.
    ANTIBIOTICS-BASEL, 2023, 12 (04):
  • [45] Ceftazidime/avibactam versus polymyxin B in carbapenem-resistant Klebsiella pneumoniae infections: a propensity score-matched multicenter real-world study
    Zhuang, Hai-Hui
    Qu, Qiang
    Long, Wen-Ming
    Hu, Qin
    Wu, Xiao-Li
    Chen, Ying
    Wan, Qing
    Xu, Tian-Tian
    Luo, Yue
    Yuan, Hai-Yan
    Lu, Qiong
    Qu, Jian
    INFECTION, 2024, : 95 - 106
  • [46] Insertion sequence mediating mrgB disruption is the major mechanism of polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from China
    Chen, Xin
    Li, Pei
    Sun, Zhewei
    Xu, Xiaogang
    Jiang, Jianping
    Su, Jiachun
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 30 : 357 - 362
  • [47] Findings from an outbreak of carbapenem-resistant Klebsiella pneumoniae emphasize the role of antibiotic treatment for cross transmission
    Stefan Borgmann
    Yvonne Pfeifer
    Laura Becker
    Beate Rieß
    Rabea Siegmund
    Ulrich Sagel
    Infection, 2018, 46 : 103 - 112
  • [48] Antimicrobial treatment of monomicrobial phenotypic carbapenem-resistant Klebsiella pneumoniae bacteremia: Two are better than one
    Tsai, Wen-Chia
    Syue, Ling-Shan
    Ko, Wen-Chien
    Lo, Ching-Lung
    Lee, Nan-Yao
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2022, 55 (06) : 1219 - 1228
  • [49] Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
    Shields, Ryan K.
    Nguyen, M. Hong
    Chen, Liang
    Press, Ellen G.
    Potoski, Brian A.
    Marini, Rachel V.
    Doi, Yohei
    Kreiswirth, Barry N.
    Clancy, Cornelius J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (08)
  • [50] Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
    Huang, Po-Han
    Chen, Wen-Yin
    Chou, Sheng-Hua
    Wang, Fu-Der
    Lin, Yi-Tsung
    MICROBIOLOGY SPECTRUM, 2022, 10 (03):
12345